# Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

> **NCT00657241** · PHASE3 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 30 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Carvedilol CR
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT00657241
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657241, "Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00657241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*